Amneal Pharmaceuticals Receives Five Generics Industry Awards for Customer Value and Service Excellence

DIANA from HDMA Caps a Stellar 18 Months

HAUPPAUGE, N.Y.--(BUSINESS WIRE)-- Amneal Pharmaceuticals is pleased to announce that the company has been honored with the Distribution Industry Award for Notable Achievements in Healthcare (DIANA) for Best Generic Product Manufacturer with Sales to Healthcare Distributors of Less Than $100 Million by the Healthcare Distribution Management Association (HDMA). The award recognizes pharmaceutical manufacturers who set the standard of excellence in best business practices with HDMA healthcare distributors. HDMA members independently voted for companies they believed demonstrated overall exceptional performance as a generics manufacturer and supplier.

The DIANA was announced at the June HDMA Business & Leadership Conference in Orlando, FL and rounds out a total of five major industry awards that Amneal has garnered in the past 18 months. Currently the 10th largest U.S. generics manufacturer in number of prescriptions dispensed, according to March 2010 data from IMS Health, the fast-growing pharmaceutical firm also earned the following honors:

  • Emerging Supplier, One Stop Sales Less Than $100 million from McKesson in May
  • 2010 Generic Vendor of the Year from Smith Drug in April
  • Generic Supplier of the Year - Under $50 Million from AmerisourceBergen in 2009
  • Cardinal Trade Representative of the Year in 2008

These prestigious awards recognize excellence across the entire Amneal organization – quality, supply, pricing, account management, customer response, leadership, innovation and collaboration – affirming the generic maker’s core focus on maximizing value creation in managing its wholesaler-distributor accounts.

“Since we launched our own label only three years ago, Amneal is extremely honored to receive industry-wide recognition by these top wholesalers-distributors,” said Jim Luce, Executive Vice President, Sales & Marketing. He continued, “We’re tremendously proud of what we have accomplished. Yet more significant than the actual awards is our customers’ validation of Amneal’s guiding principles, business philosophy and aggressive yet strategic growth plan. Our relentless focus on these fundamentals enables us to maximize value for our customers and, most importantly, our customers’ customers.”

Amneal Pharmaceuticals LLC, headquartered in Hauppauge, NY is a U.S.-based firm that develops, manufactures and distributes generic pharmaceuticals regulated and approved by the U.S. FDA. Known as “Generic’s New Generation”, the company utilizes its newly expanded R&D and manufacturing capabilities to conceive breakthrough developments with lasting impact for a robust product pipeline. Rapid ANDA approvals and diverse product acquisitions are key to Amneal’s aggressive growth strategy, as is the company’s strong commitment to deep customer relationships and maximum value creation. Amneal delivers high quality products, superior service levels and dynamic value throughout the pharmaceutical industry. For more information, visit www.amneal.com.



CONTACT:

Amneal Pharmaceuticals, LLC
Jim Luce
Executive Vice President, Sales & Marketing
Direct: 949-610-8018
Fax: 949-610-8218
E-mail: [email protected]
www.amneal.com

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Pharmaceutical  Retail  Other Retail  FDA  Managed Care

MEDIA:

Logo
 Logo

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.